Joshua T. Brumm - CEO & President, Director at Dyne Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO & President, Director
Stock Symbol
DYN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Joshua T. Brumm - trading volume in the past year for Dyne Therapeutics, Inc.

Holdings reported by Joshua T. Brumm for Dyne Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 537,998 $14 M $25.93 Mar 11, 2024 Direct
Stock option (right to buy) 83,269 Mar 11, 2024 Direct Common Stock

Transactions reported by Joshua T. Brumm for Dyne Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership